beta 2 Defensin Protein

Produktnummer ABIN2719356

Dieses Recombinant beta 2 Defensin-Protein wird in Escherichia coli (E. coli) produziert.

Kurzübersicht für beta 2 Defensin Protein (ABIN2719356)

Target: beta 2 Defensin (BD-2) (Defensin beta 2 (BD-2))

Protein-Typ: Recombinant

Spezies: Human

Quelle: Escherichia coli (E. coli)

Applikation: Antibody Production (AbP), Standard (STD)

Reinheit: > 95 % as determined by SDS-PAGE and Coomassie blue staining

Produktdetails

Produktmerkmale:

• Recombinant human Defensin beta 2 protein expressed in E. coli.
• Produced with end-sequenced ORF clone

Endotoxin-Niveau: < 0.1 EU per μg protein as determined by LAL test

Anwendungsinformationen

Applikationshinweise: Recombinant human proteins can be used for:
Native antigens for optimized antibody production
Positive controls in ELISA and other antibody assays

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Buffer: Lyophilized from a 0.2 μM filtered solution of 20 mM Phosphate buffer, 130 mM NaCl, pH 7.4. Stable for at least 6 months from date of receipt under proper storage and handling conditions.

Lagerung: -80 °C

Informationen zur Lagerung: Store at -80°C. Thaw on ice, aliquot to individual single-use tubes, and then re-freeze immediately. Only 2-3 freeze thaw cycles are recommended.

Antigendetails

Target: beta 2 Defensin (BD-2) (Defensin beta 2 (BD-2))

Andere Bezeichnung: Defensin beta 2

Hintergrund: Defensins form a family of microbicidal and cytotoxic peptides made by neutrophils. Members of the defensin family are highly similar in protein sequence. This gene encodes defensin, beta 4, an antibiotic peptide which is locally regulated by inflammation.

Molekulargewicht: 4.3 kDa

NCBI Accession: NP_004933